Jorge Reyes‐Esparza

ORCID: 0000-0001-7978-540X · 3 papers in corpus
article 2011
Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
·doi:10.1016/s1665-2681(19)31513-3

BACKGROUND: Thrombocytopenia is a common hematologic disorder observed in patients with chronic hepatitis C virus (HCV) infection. Combined peginterferon (PEG-INF) and ribavirin treatment may exacerbate thrombocytopenia in patients with HCV…

article 2010
Danazol in the treatment of thrombocytopenia associated with the use of peg‐interferon alfa 2a and Ribavirin in patients with chronic hepatitis C
·doi:10.1096/fasebj.24.1_supplement.964.2

The aim of this study was to assess the effectiveness of danazol in thrombocytopenia associated with the use of peg‐interferon alfa2a y ribavirin (IFN + RIBA) in patients with chronic hepatitis C (HCV). A clinical trial open, prospective, w…

article 2007
Effect of Peg‐Interferon, Ribavirin and Danazol on experimental fibrosis induced in rats
·doi:10.1096/fasebj.21.5.a443-a

The current standard therapy of patients with chronic hepatitis C is the combination of peg‐interferon (IFN)‐α and ribavirin.However, it is well known that interferon in combination with ribavirin treatment may exacerbate the neutropenia an…